Patent · US Active

Combination formulation of two antiviral compounds

US9757406B2 · kind B2 · utility

7Cited by

16References

16Claims

0Family size

Assignee

Gilead Pharmasset LLC · US

Inventors

Eric Gorman · Hayward, US
Erik Mogalian · Redwood City, US
Reza Oliyai · Burlingame, US
Dimitrios Stefanidis · Saratoga, US
Lauren Wiser · San Francisco, US
Vahid Zia · Palo Alto, US

Key dates

Filing date	Sep 30, 2016
Grant date	Sep 12, 2017
Priority date	—
Expiry date	Sep 30, 2036

Classification

Technology area (CPC A)Human Necessities
CPC primaryA61P43/00
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

Disclosed are pharmaceutical compositions comprising Compound I, having the formula:and an effective amount of sofosbuvir wherein the sofosbuvir is substantially crystalline. Also disclosed are methods of use for the pharmaceutical composition.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.